CD
TXMD icon

Carl Domino’s TherapeuticsMD TXMD Stock Holding History

Carl Domino’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$193K Sell
730
-160
-18% -$46.3K 0.24% 100
2017
Q2 		$235K Buy
+890
New +$223K 0.27% 92

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Carl Domino's TXMD Position: Q3 2017 in Review

Carl Domino reduced its TherapeuticsMD (TXMD) stake by 18% in Q3 2017, selling an estimated $46.3K and leaving 730 shares worth $193K. The position accounts for 0.24% of the portfolio, ranked #100.

Carl Domino first reported a position in TXMD in Q2 2017 and has held it in 2 quarters since. The position peaked at $235K in Q2 2017. 134 funds tracked by Wall St. Rank hold TXMD as of Q3 2017.

  • Carl Domino held 730 shares of TherapeuticsMD worth $193K as of Q3 2017.
  • Carl Domino sold 160 TherapeuticsMD shares in Q3 2017, an estimated $46.3K.
  • TherapeuticsMD made up 0.24% of Carl Domino's portfolio in Q3 2017, its #100 holding.
  • Carl Domino first reported a position in TherapeuticsMD in Q2 2017 and has held it in 2 quarters since.
  • Carl Domino's TherapeuticsMD position peaked at $235K in Q2 2017.
  • 134 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2017.

Based on Carl Domino's 13F filing for Q3 2017, filed 7 Nov 2017.